Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Sonoma Pharmaceuticals, Inc. (SNOA) had Profit Margin of -18.83% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$4.35M |
|
$-0.82M |
|
$2.70M |
|
$1.65M |
|
$5.03M |
|
$-0.68M |
|
$-0.27M |
|
$-0.95M |
|
$-0.95M |
|
$-0.82M |
|
$-0.82M |
|
$-0.82M |
|
$-0.82M |
|
$-0.68M |
|
$-0.64M |
|
1.71M |
|
1.71M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$12.14M |
|
$0.31M |
|
$1.48M |
|
$13.62M |
|
$4.22M |
|
-- |
|
$5.97M |
|
$10.19M |
|
$3.43M |
|
$3.43M |
|
$3.43M |
|
1.73M |
|
| Cash Flow Statement Financials | |
$-3.41M |
|
$-0.16M |
|
$0.09M |
|
$5.37M |
|
$2.56M |
|
$-2.81M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
37.94% |
|
-15.59% |
|
-15.59% |
|
-- |
|
-21.82% |
|
|
Profit Margin |
-18.83% |
$-3.58M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
0.73 |
|
1.83 |
|
49.29 |
|
-23.86% |
|
-23.86% |
|
-6.01% |
|
-23.86% |
|
$1.98 |
|
$-2.09 |
|
$-1.99 |
|